About this trial
Maxillary transverse deficiency is an orthodontic anomaly characterized by the upper and lower dental arches being incompatible due to insufficient width of the maxilla. This condition typically manifests with clinical symptoms such as crossbite, crowding of teeth, and impaired respiratory function. Genetic factors, early primary tooth loss, mouth breathing, thumb sucking, and abnormal swallowing are among the causes of maxillary narrowing. Treatment options vary depending on the patient's age and the degree of suture closure. In pediatric and adolescent patients, rapid (RPE) or slow (SPE) orthodontic expansion can be achieved with palatal expansion appliances. However, in adult patients, due to the less flexible bone structure of the maxilla, methods such as surgically assisted expansion (SARME) or mini-screw-assisted expansion (MARPE) are preferred. Recent studies have shown that MARPE can be effective as a non-surgical alternative in young adults and can provide direct skeletal expansion without damaging the teeth.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of maxillary transverse deficiency.
Patients aged 15 years and older.
Presence of unilateral or bilateral crossbite.
Disqualifiers
Severe facial deformities or craniofacial syndromes.
History of previous orthodontic treatment.
Existing pathology or history of surgery related to the paranasal sinuses, nasolacrimal system, or orbital cavity.
Inadequate patient cooperation.
Trial design
Parallel
Treatments tested in this trial
MARPE (Mini-Screw Assisted Rapid Palatal Expansion)
DeviceA mini-screw assisted rapid palatal expansion device used to achieve skeletal maxillary expansion through bicortical anchorage. The device delivers orthopedic forces to the maxillary sutures with reduced dental tipping and greater skeletal effects compared to conventional rapid palatal expansion appliances.
SARME (Surgically Assisted Rapid Maxillary Expansion)
Procedure/SurgeryA surgically assisted maxillary expansion procedure performed to facilitate skeletal expansion in skeletally mature patients. The procedure involves weakening areas of resistance in the maxilla (e.g., lateral walls, midpalatal suture) followed by activation with a rapid palatal expansion device to achieve transverse maxillary widening.
Treatment groups
Trial outcomes
Primary outcomes
Changes in Craniofacial Volumes
Evaluation of volumetric changes using CBCT analysis. Specific measurements include the total volume of the nasolacrimal and nasopalatine canals, maxillary sinus volume, and nasal airway volume.
Changes in Linear Dimensions of Canals and Ostium
Assessment of linear changes including the anteroposterior and transverse diameters and lengths of the nasolacrimal and nasopalatine canals. Additionally, the diameter of the maxillary sinus ostium openings will be measured in millimeters.
Changes in Angulation and Septal Deviation
Assessment of angular changes in craniofacial structures. This includes the angulation of the nasolacrimal and nasopalatine canals and the degree of nasal septal deviation.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Merve Kulaksız
Lead sponsor
Bezmialem Vakif University
Sponsor institution